Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)

Ironwood Pharmaceuticals' Liabilities from Discontinued Operations history spans 1 years, with the latest figure at 15739000.0 for Q4 2018.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 15739000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was 15739000.0, a N/A change, with the full-year FY2018 number at 15739000.0, changed N/A from a year prior.
Liabilities from Discontinued Operations hit 15739000.0 in Q4 2018 for Ironwood Pharmaceuticals.
Over the last five years, Liabilities from Discontinued Operations for IRWD hit a ceiling of 15739000.0 in Q4 2018 and a floor of 15739000.0 in Q4 2018.